CAELUM Co., Ltd. (KOSDAQ:258610)
1,191.00
+7.00 (0.59%)
At close: Oct 8, 2026
CAELUM Revenue
CAELUM had revenue of 13.66B KRW in the quarter ending June 30, 2026, a decrease of -20.23%. This brings the company's revenue in the last twelve months to 73.67B, down -21.62% year-over-year. In the year 2025, CAELUM had annual revenue of 81.70B, down -16.06%. That makes CAELUM the 27,222nd largest company in the world by revenue and 1,643rd in South Korea.
Revenue (ttm)
73.67B
Revenue Growth
-21.62%
P/S Ratio
0.59
Revenue / Employee
1.94B
Employees
38
Market Cap
43.15B
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 81.70B | -15.63B | -16.06% |
| Dec 31, 2024 | 97.33B | 12.78B | 15.12% |
| Dec 31, 2023 | 84.55B | 6.70B | 8.61% |
| Dec 31, 2022 | 77.84B | 24.92B | 47.09% |
| Dec 31, 2021 | 52.92B | 41.43B | 360.57% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Wooree Bio Co.,Ltd | 1.10T |
| Winix | 432.03B |
| Genoray | 107.88B |
| GeneBioTech Co. ,Ltd | 89.31B |
| Abko Co., Ltd. | 81.76B |
| Zero to Seven | 70.73B |
| KEYEAST.Co.,Ltd. | 57.23B |
| ELUON | 57.11B |